{{knowledge objective
|Identifiant=OIC-071-25-B
|Item_parent=Eating disorders in adolescents and adults (see item 253)
|Item_parent_short=Eating disorders in adolescents and adults (see item 253)
|Rank=B
|Title=Knowing the principles of pharmacotherapy
|Description=Know that fluoxetine has a marketing authorisation for BN (higher dosage than for the treatment of depressive episodes).
|Rubric=Management
|Contributors=
|Order=25}}
'''Pharmacological management''''

The only drug with marketing authorisation is fluoxetine (at a higher dosage than in the case of major depressive episodes).